The 44 rating InvestorsObserver gives to MEI Pharma Inc (MEIP) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 36 percent of stocks in the Biotechnology industry, MEIP’s 44 overall rating means the stock scores better than 44 percent of all stocks.
MEIP has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on MEIP!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 44 would rank higher than 44 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With MEI Pharma Inc Stock Today?
MEI Pharma Inc (MEIP) stock has risen 3.68% while the S&P 500 is down -0.46% as of 9:49 AM on Monday, Mar 11. MEIP has risen $0.14 from the previous closing price of $3.80 on volume of 16,093 shares. Over the past year the S&P 500 is up 32.28% while MEIP is down -23.05%. MEIP earned $2.98 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 1.32.
Click Here to get the full Stock Report for MEI Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
